Is Molina Healthcare (MOH) a Great Value Stock Right Now?

According to Zacks, Molina Healthcare (MOH) is currently a value stock to consider, holding a Zacks Rank #2 (Buy) and an 'A' grade for Value. MOH's P/E ratio of 11.32 is slightly below its industry's average, and its PEG ratio of 0.93 is also lower than the industry average of 1.10, suggesting the stock may be undervalued given its earnings growth prospects.

Analysis

Molina Healthcare (MOH) is highlighted as a potentially undervalued stock, supported by a Zacks Rank #2 (Buy) and an 'A' grade for Value within the Zacks Style Scores system. The company's current price-to-earnings (P/E) ratio of 11.32 is slightly below its industry's average of 11.79. An examination of its 52-week forward P/E, which ranged from 10.15 to 14.07 with a median of 12.25, indicates its current P/E is in the lower portion of its recent historical band. Furthermore, MOH's price/earnings-to-growth (PEG) ratio is 0.93, comparing favorably to the industry average of 1.10 and its own 52-week median of 1.00. These valuation metrics, which also show the current PEG near the lower end of its 0.81 to 1.24 range over the past year, coupled with a strong earnings outlook as implied by the Zacks Rank methodology focusing on earnings estimates and revisions, suggest that MOH could be an attractive value proposition at its current market price. The strongly positive sentiment score of 0.8 for MOH further underpins this favorable assessment.

Key Decisions for Investors

• Investors seeking value opportunities may consider Molina Healthcare for further investigation, given its Zacks Rank #2 (Buy), 'A' Value grade, and valuation metrics that sit below industry averages and historical medians.
• The current P/E ratio of 11.32 and PEG ratio of 0.93 indicate potential undervaluation relative to peers and the company's own earnings growth prospects, warranting a closer look at its fundamental strength.
• It is advisable to monitor Molina Healthcare's upcoming earnings reports and any changes in analyst earnings estimates, as these are critical inputs to the Zacks Rank and will be key to validating the ongoing value thesis.